December 11, 2025 a 06:00 pm
HOLX: Fundamental Ratio Analysis - Hologic, Inc.
Hologic, Inc. is a key player in the healthcare sector, particularly focusing on women's health through diagnostics and surgical products. The company operates through diverse segments, demonstrating strong international presence. This analysis provides an overview of its fundamental ratings, historical performance, analyst targets, and overall market sentiment.
Fundamentals Rating
The fundamental analysis of HOLX indicates a relatively stable performance with a mixed evaluation across different financial metrics. Below are the individual scores and their visual representation.
| Category | Score | Visual |
|---|---|---|
| Overall Rating | B+ | |
| Discounted Cash Flow | 5 | |
| Return on Equity | 4 | |
| Return on Assets | 5 | |
| Debt to Equity | 1 | |
| Price to Earnings | 2 | |
| Price to Book | 2 |
Historical Rating
The historical scores reflect slight changes over time, providing insights into the company's performance consistency and fundamental reliability.
| Date | Overall | DCF | ROE | ROA | Debt/Equity | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-12-11 | 3 | 5 | 4 | 5 | 1 | 2 | 2 |
| Previous | 0 | 5 | 4 | 5 | 1 | 2 | 2 |
Analyst Price Targets
Analyst targets for Hologic suggest modest fluctuations with a median consensus pointing toward steady performance. The following table summarizes their predictions.
| High | Low | Median | Consensus |
|---|---|---|---|
| 79 | 76 | 78 | 77.8 |
Analyst Sentiment
The sentiment among analysts reveals a balanced perspective with a majority of 'Hold' ratings. The distribution of recommendations is delineated below.
| Recommendation | Count | Visual |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 20 | |
| Hold | 21 | |
| Sell | 1 | |
| Strong Sell | 0 |
Conclusion
Hologic, Inc. is positioned as a stable entity in the healthcare market, particularly in women's health. While the company's financials display overall strength, its mixed score ratings suggest areas for improvement, specifically in debt management and valuation ratios. Analysts' mixed sentiment and pricing targets indicate potential but cautious market optimism. For investors, HOLX presents itself as a reliable choice, though careful consideration of risks is advised.